Starting a successful hepatic artery infusion pump program: A practical guide
Implementation of a successful hepatic artery infusion pump program requires numerous factors to be in place, and the lack of any of these may lead to program failure. First and foremost, hepatic artery infusion pump programs must have adequate surgical expertise in the complex technical aspects of...
Gespeichert in:
Veröffentlicht in: | Surgery 2023-07, Vol.174 (1), p.101-105 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 105 |
---|---|
container_issue | 1 |
container_start_page | 101 |
container_title | Surgery |
container_volume | 174 |
creator | McDonald, Hannah G. Patel, Reema A. Ellis, Carleton S. Gholami, Sepideh Barry-Hundeyin, Mautin Pandalai, Prakash K. Kim, Joseph Cavnar, Michael J. |
description | Implementation of a successful hepatic artery infusion pump program requires numerous factors to be in place, and the lack of any of these may lead to program failure. First and foremost, hepatic artery infusion pump programs must have adequate surgical expertise in the complex technical aspects of hepatic artery infusion pump implantation and postoperative management. Most new hepatic artery infusion pump programs are initiated by a surgeon and led in conjunction with a medical oncologist. Medical oncology experience in floxuridine dosing is critical in maximizing the treatment doses and the number of cycles administered while avoiding biliary toxicity. This is facilitated by collaboration with an engaged pharmacy team. To have adequate patient volume for a successful program, internal and external stakeholders must have buy-in, including surgical and medical oncology colleagues unfamiliar with hepatic artery infusion pumps, colorectal surgery, and other referring providers. Programmatic support must be obtained from the hospital, cancer center, and department administration. Day-to-day pump access for chemotherapy and maintenance saline fills must be performed by appropriately trained infusion nurses to avoid complications. Nuclear and diagnostic radiology experience is key to identifying extrahepatic perfusion and hepatic artery infusion pump–specific complications. Additionally, skilled interventional radiologists and gastroenterologists are necessary to identify and treat rare complications rapidly. Finally, given the current rapid expansion of hepatic artery infusion pump programs, new programs must identify engaged mentors to help guide patient selection, navigate the nuanced issues that may arise, and provide advice in the case of complications. Although hepatic artery infusion pump dissemination outside of several major tertiary centers previously had stalled, establishing a successful and active hepatic artery infusion pump is feasible with appropriate training, mentorship, and thoughtful assembly of a dedicated multidisciplinary team. |
doi_str_mv | 10.1016/j.surg.2023.03.026 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2809547406</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0039606023001721</els_id><sourcerecordid>2809547406</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-5d5b5329658fe2744e6de5e7442005cea119466dac7e55736d0a9f9a8e072e433</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMotn78AQ-So5etk2ST7YqXUvwCxYN6DjE7W1P2y2Qj-O9NafUoDMzAPPMy70vIGYMZA6Yu17MQ_WrGgYsZpOJqj0yZFDwrhGL7ZAogykyBggk5CmENAGXO5odkIgomiiKHKXl6GY0fXbeihoZoLYZQx4Z-4GBGZ2naof-mrqtjcH1Hh9gOdPD9ypv2ii7SaGziTENX0VV4Qg5q0wQ83fVj8nZ787q8zx6f7x6Wi8fMCqnGTFbyPb1ZKjmvkRd5jqpCiWngANKiYazMlaqMLVDKZKYCU9almSMUHHMhjsnFVje98hkxjLp1wWLTmA77GDSfQynzZFAllG9R6_sQPNZ68K41_lsz0JsY9VpvYtSbGDWk4puj851-fG-x-jv5zS0B11sAk8svh14H67CzWDmPdtRV7_7T_wGiqINw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2809547406</pqid></control><display><type>article</type><title>Starting a successful hepatic artery infusion pump program: A practical guide</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>McDonald, Hannah G. ; Patel, Reema A. ; Ellis, Carleton S. ; Gholami, Sepideh ; Barry-Hundeyin, Mautin ; Pandalai, Prakash K. ; Kim, Joseph ; Cavnar, Michael J.</creator><creatorcontrib>McDonald, Hannah G. ; Patel, Reema A. ; Ellis, Carleton S. ; Gholami, Sepideh ; Barry-Hundeyin, Mautin ; Pandalai, Prakash K. ; Kim, Joseph ; Cavnar, Michael J.</creatorcontrib><description>Implementation of a successful hepatic artery infusion pump program requires numerous factors to be in place, and the lack of any of these may lead to program failure. First and foremost, hepatic artery infusion pump programs must have adequate surgical expertise in the complex technical aspects of hepatic artery infusion pump implantation and postoperative management. Most new hepatic artery infusion pump programs are initiated by a surgeon and led in conjunction with a medical oncologist. Medical oncology experience in floxuridine dosing is critical in maximizing the treatment doses and the number of cycles administered while avoiding biliary toxicity. This is facilitated by collaboration with an engaged pharmacy team. To have adequate patient volume for a successful program, internal and external stakeholders must have buy-in, including surgical and medical oncology colleagues unfamiliar with hepatic artery infusion pumps, colorectal surgery, and other referring providers. Programmatic support must be obtained from the hospital, cancer center, and department administration. Day-to-day pump access for chemotherapy and maintenance saline fills must be performed by appropriately trained infusion nurses to avoid complications. Nuclear and diagnostic radiology experience is key to identifying extrahepatic perfusion and hepatic artery infusion pump–specific complications. Additionally, skilled interventional radiologists and gastroenterologists are necessary to identify and treat rare complications rapidly. Finally, given the current rapid expansion of hepatic artery infusion pump programs, new programs must identify engaged mentors to help guide patient selection, navigate the nuanced issues that may arise, and provide advice in the case of complications. Although hepatic artery infusion pump dissemination outside of several major tertiary centers previously had stalled, establishing a successful and active hepatic artery infusion pump is feasible with appropriate training, mentorship, and thoughtful assembly of a dedicated multidisciplinary team.</description><identifier>ISSN: 0039-6060</identifier><identifier>EISSN: 1532-7361</identifier><identifier>DOI: 10.1016/j.surg.2023.03.026</identifier><identifier>PMID: 37137740</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Colorectal Neoplasms ; Floxuridine - therapeutic use ; Hepatic Artery ; Humans ; Infusion Pumps, Implantable ; Infusions, Intra-Arterial ; Liver Neoplasms - surgery</subject><ispartof>Surgery, 2023-07, Vol.174 (1), p.101-105</ispartof><rights>2023 Elsevier Inc.</rights><rights>Copyright © 2023 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-5d5b5329658fe2744e6de5e7442005cea119466dac7e55736d0a9f9a8e072e433</citedby><cites>FETCH-LOGICAL-c356t-5d5b5329658fe2744e6de5e7442005cea119466dac7e55736d0a9f9a8e072e433</cites><orcidid>0000-0002-6197-7945</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.surg.2023.03.026$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37137740$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McDonald, Hannah G.</creatorcontrib><creatorcontrib>Patel, Reema A.</creatorcontrib><creatorcontrib>Ellis, Carleton S.</creatorcontrib><creatorcontrib>Gholami, Sepideh</creatorcontrib><creatorcontrib>Barry-Hundeyin, Mautin</creatorcontrib><creatorcontrib>Pandalai, Prakash K.</creatorcontrib><creatorcontrib>Kim, Joseph</creatorcontrib><creatorcontrib>Cavnar, Michael J.</creatorcontrib><title>Starting a successful hepatic artery infusion pump program: A practical guide</title><title>Surgery</title><addtitle>Surgery</addtitle><description>Implementation of a successful hepatic artery infusion pump program requires numerous factors to be in place, and the lack of any of these may lead to program failure. First and foremost, hepatic artery infusion pump programs must have adequate surgical expertise in the complex technical aspects of hepatic artery infusion pump implantation and postoperative management. Most new hepatic artery infusion pump programs are initiated by a surgeon and led in conjunction with a medical oncologist. Medical oncology experience in floxuridine dosing is critical in maximizing the treatment doses and the number of cycles administered while avoiding biliary toxicity. This is facilitated by collaboration with an engaged pharmacy team. To have adequate patient volume for a successful program, internal and external stakeholders must have buy-in, including surgical and medical oncology colleagues unfamiliar with hepatic artery infusion pumps, colorectal surgery, and other referring providers. Programmatic support must be obtained from the hospital, cancer center, and department administration. Day-to-day pump access for chemotherapy and maintenance saline fills must be performed by appropriately trained infusion nurses to avoid complications. Nuclear and diagnostic radiology experience is key to identifying extrahepatic perfusion and hepatic artery infusion pump–specific complications. Additionally, skilled interventional radiologists and gastroenterologists are necessary to identify and treat rare complications rapidly. Finally, given the current rapid expansion of hepatic artery infusion pump programs, new programs must identify engaged mentors to help guide patient selection, navigate the nuanced issues that may arise, and provide advice in the case of complications. Although hepatic artery infusion pump dissemination outside of several major tertiary centers previously had stalled, establishing a successful and active hepatic artery infusion pump is feasible with appropriate training, mentorship, and thoughtful assembly of a dedicated multidisciplinary team.</description><subject>Colorectal Neoplasms</subject><subject>Floxuridine - therapeutic use</subject><subject>Hepatic Artery</subject><subject>Humans</subject><subject>Infusion Pumps, Implantable</subject><subject>Infusions, Intra-Arterial</subject><subject>Liver Neoplasms - surgery</subject><issn>0039-6060</issn><issn>1532-7361</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LAzEQhoMotn78AQ-So5etk2ST7YqXUvwCxYN6DjE7W1P2y2Qj-O9NafUoDMzAPPMy70vIGYMZA6Yu17MQ_WrGgYsZpOJqj0yZFDwrhGL7ZAogykyBggk5CmENAGXO5odkIgomiiKHKXl6GY0fXbeihoZoLYZQx4Z-4GBGZ2naof-mrqtjcH1Hh9gOdPD9ypv2ii7SaGziTENX0VV4Qg5q0wQ83fVj8nZ787q8zx6f7x6Wi8fMCqnGTFbyPb1ZKjmvkRd5jqpCiWngANKiYazMlaqMLVDKZKYCU9almSMUHHMhjsnFVje98hkxjLp1wWLTmA77GDSfQynzZFAllG9R6_sQPNZ68K41_lsz0JsY9VpvYtSbGDWk4puj851-fG-x-jv5zS0B11sAk8svh14H67CzWDmPdtRV7_7T_wGiqINw</recordid><startdate>202307</startdate><enddate>202307</enddate><creator>McDonald, Hannah G.</creator><creator>Patel, Reema A.</creator><creator>Ellis, Carleton S.</creator><creator>Gholami, Sepideh</creator><creator>Barry-Hundeyin, Mautin</creator><creator>Pandalai, Prakash K.</creator><creator>Kim, Joseph</creator><creator>Cavnar, Michael J.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6197-7945</orcidid></search><sort><creationdate>202307</creationdate><title>Starting a successful hepatic artery infusion pump program: A practical guide</title><author>McDonald, Hannah G. ; Patel, Reema A. ; Ellis, Carleton S. ; Gholami, Sepideh ; Barry-Hundeyin, Mautin ; Pandalai, Prakash K. ; Kim, Joseph ; Cavnar, Michael J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-5d5b5329658fe2744e6de5e7442005cea119466dac7e55736d0a9f9a8e072e433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Colorectal Neoplasms</topic><topic>Floxuridine - therapeutic use</topic><topic>Hepatic Artery</topic><topic>Humans</topic><topic>Infusion Pumps, Implantable</topic><topic>Infusions, Intra-Arterial</topic><topic>Liver Neoplasms - surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McDonald, Hannah G.</creatorcontrib><creatorcontrib>Patel, Reema A.</creatorcontrib><creatorcontrib>Ellis, Carleton S.</creatorcontrib><creatorcontrib>Gholami, Sepideh</creatorcontrib><creatorcontrib>Barry-Hundeyin, Mautin</creatorcontrib><creatorcontrib>Pandalai, Prakash K.</creatorcontrib><creatorcontrib>Kim, Joseph</creatorcontrib><creatorcontrib>Cavnar, Michael J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McDonald, Hannah G.</au><au>Patel, Reema A.</au><au>Ellis, Carleton S.</au><au>Gholami, Sepideh</au><au>Barry-Hundeyin, Mautin</au><au>Pandalai, Prakash K.</au><au>Kim, Joseph</au><au>Cavnar, Michael J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Starting a successful hepatic artery infusion pump program: A practical guide</atitle><jtitle>Surgery</jtitle><addtitle>Surgery</addtitle><date>2023-07</date><risdate>2023</risdate><volume>174</volume><issue>1</issue><spage>101</spage><epage>105</epage><pages>101-105</pages><issn>0039-6060</issn><eissn>1532-7361</eissn><abstract>Implementation of a successful hepatic artery infusion pump program requires numerous factors to be in place, and the lack of any of these may lead to program failure. First and foremost, hepatic artery infusion pump programs must have adequate surgical expertise in the complex technical aspects of hepatic artery infusion pump implantation and postoperative management. Most new hepatic artery infusion pump programs are initiated by a surgeon and led in conjunction with a medical oncologist. Medical oncology experience in floxuridine dosing is critical in maximizing the treatment doses and the number of cycles administered while avoiding biliary toxicity. This is facilitated by collaboration with an engaged pharmacy team. To have adequate patient volume for a successful program, internal and external stakeholders must have buy-in, including surgical and medical oncology colleagues unfamiliar with hepatic artery infusion pumps, colorectal surgery, and other referring providers. Programmatic support must be obtained from the hospital, cancer center, and department administration. Day-to-day pump access for chemotherapy and maintenance saline fills must be performed by appropriately trained infusion nurses to avoid complications. Nuclear and diagnostic radiology experience is key to identifying extrahepatic perfusion and hepatic artery infusion pump–specific complications. Additionally, skilled interventional radiologists and gastroenterologists are necessary to identify and treat rare complications rapidly. Finally, given the current rapid expansion of hepatic artery infusion pump programs, new programs must identify engaged mentors to help guide patient selection, navigate the nuanced issues that may arise, and provide advice in the case of complications. Although hepatic artery infusion pump dissemination outside of several major tertiary centers previously had stalled, establishing a successful and active hepatic artery infusion pump is feasible with appropriate training, mentorship, and thoughtful assembly of a dedicated multidisciplinary team.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>37137740</pmid><doi>10.1016/j.surg.2023.03.026</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0002-6197-7945</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0039-6060 |
ispartof | Surgery, 2023-07, Vol.174 (1), p.101-105 |
issn | 0039-6060 1532-7361 |
language | eng |
recordid | cdi_proquest_miscellaneous_2809547406 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Colorectal Neoplasms Floxuridine - therapeutic use Hepatic Artery Humans Infusion Pumps, Implantable Infusions, Intra-Arterial Liver Neoplasms - surgery |
title | Starting a successful hepatic artery infusion pump program: A practical guide |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T22%3A14%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Starting%20a%20successful%20hepatic%20artery%20infusion%20pump%20program:%20A%20practical%20guide&rft.jtitle=Surgery&rft.au=McDonald,%20Hannah%20G.&rft.date=2023-07&rft.volume=174&rft.issue=1&rft.spage=101&rft.epage=105&rft.pages=101-105&rft.issn=0039-6060&rft.eissn=1532-7361&rft_id=info:doi/10.1016/j.surg.2023.03.026&rft_dat=%3Cproquest_cross%3E2809547406%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2809547406&rft_id=info:pmid/37137740&rft_els_id=S0039606023001721&rfr_iscdi=true |